Biodesix INC Schedule 13G passive stakes

Soleus Capital Master Fund, L.P. and affiliated entities have reported beneficial ownership of 5.1% of Biodesix Inc. common stock.

Perceptive Advisors and affiliated entities have filed a Schedule 13G reporting a 4.6% beneficial ownership stake in Biodesix, Inc.

Soleus Capital Master Fund and affiliated entities have filed a Schedule 13G reporting a 4.1% beneficial ownership stake in Biodesix, Inc.

AIGH Capital Management LLC and affiliated entities report beneficial ownership of 7.7% of Biodesix, Inc. common stock as of March 31, 2026.

Telemark Asset Management, Telemark Fund, and Colin McNay jointly report a 5.4% beneficial ownership in Biodesix, Inc. common stock.

Telemark Asset Management and affiliates have filed an exit Schedule 13G/A, reporting their beneficial ownership in Biodesix, Inc. has fallen to 4.1%.

Soleus Capital Master Fund and related entities have reported a 6.3% beneficial ownership stake in Biodesix Inc., totaling 500,000 common shares.

Perceptive Advisors LLC, along with its affiliates and Joseph Edelman, has disclosed a collective beneficial ownership of 5.1% in Biodesix, Inc., totaling 7,673,880 shares, including exercisable warrants.

Perceptive Advisors LLC, along with its affiliates and Joseph Edelman, has disclosed a combined beneficial ownership of 4.5% in Biodesix, Inc., including common stock and exercisable warrants.